Published in Biosci Rep on October 01, 2011
SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth. EMBO J (2015) 0.87
Biochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogaster. Biochem J (2012) 0.82
Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation. Sci Signal (2015) 0.81
Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine. J Biol Chem (2014) 0.79
Kynurenine Aminotransferase Isozyme Inhibitors: A Review. Int J Mol Sci (2016) 0.75
Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Cell Mol Life Sci (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Synaptic plasticity and memory: an evaluation of the hypothesis. Annu Rev Neurosci (2000) 8.20
wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. Acta Crystallogr D Biol Crystallogr (1997) 5.58
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 2.99
Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov (2002) 2.61
The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci (2001) 2.61
Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev (2010) 2.44
Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther (2002) 2.37
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem (2006) 2.16
Evolutionary recruitment of biochemically specialized subdivisions of Family I within the protein superfamily of aminotransferases. J Bacteriol (1996) 1.59
Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. Biochem Pharmacol (2005) 1.57
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. J Mol Biol (1992) 1.49
Unconventional ligands and modulators of nicotinic receptors. J Neurobiol (2002) 1.43
Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol (1988) 1.37
Crystal structures of Escherichia coli aspartate aminotransferase in two conformations. Comparison of an unliganded open and two liganded closed forms. J Mol Biol (1994) 1.32
Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta (2009) 1.32
Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J Neurosci (2004) 1.23
X-ray crystallographic study of pyridoxal 5'-phosphate-type aspartate aminotransferases from Escherichia coli in open and closed form. J Biochem (1994) 1.21
Refinement and comparisons of the crystal structures of pig cytosolic aspartate aminotransferase and its complex with 2-methylaspartate. J Biol Chem (1997) 1.20
Kynurenine aminotransferase and glutamine transaminase K of Escherichia coli: identity with aspartate aminotransferase. Biochem J (2001) 1.19
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci (2009) 1.19
X-ray crystallographic study of pyridoxamine 5'-phosphate-type aspartate aminotransferases from Escherichia coli in three forms. J Biochem (1994) 1.17
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem (2007) 1.15
Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem (2009) 1.13
The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem (1994) 1.12
Glutamate transport and metabolism in astrocytes. Glia (1997) 1.11
Response of brain amino acid metabolism to ketosis. Neurochem Int (2005) 1.08
Neuronal death in vitro: parallelism between survivability of hippocampal neurones and sustained elevation of cytosolic Ca2+ after exposure to glutamate receptor agonist. Exp Brain Res (1988) 1.08
Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res (1997) 1.08
Crystal structure of human kynurenine aminotransferase I. J Biol Chem (2004) 1.08
Differential distribution of the enzymes glutamate dehydrogenase and aspartate aminotransferase in cortical synaptic mitochondria contributes to metabolic compartmentation in cortical synaptic terminals. Neurochem Int (2000) 1.07
Two kynurenine aminotransferases in human brain. Brain Res (1991) 1.07
pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem (2004) 1.04
Energy metabolism in glutamatergic neurons, GABAergic neurons and astrocytes in primary cultures. Neurochem Res (1988) 1.03
Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain. Front Biosci (1998) 1.02
Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol (1993) 1.02
Crystal structure of human kynurenine aminotransferase II. J Biol Chem (2007) 1.00
Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase. Arch Biochem Biophys (2008) 1.00
Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev Neurosci (1993) 1.00
Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related. Proc Natl Acad Sci U S A (1990) 0.99
Regulation of energy metabolism in synaptic terminals and cultured rat brain astrocytes: differences revealed using aminooxyacetate. Dev Neurosci (1993) 0.99
Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep (2008) 0.99
Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia. J Biol Chem (2007) 0.98
Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol Cell Biol (2008) 0.98
The pharmacological manipulation of glutamate receptors and neuroprotection. Eur J Pharmacol (2002) 0.97
Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Eur J Neurosci (2007) 0.96
Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene (2006) 0.95
Crystal structure of the closed form of chicken cytosolic aspartate aminotransferase at 1.9 A resolution. J Mol Biol (1995) 0.95
Evaluation of the importance of transamination versus deamination in astrocytic metabolism of [U-13C]glutamate. Glia (1996) 0.93
Evidence that aspartate aminotransferase activity and ketodicarboxylate carrier function are essential for biosynthesis of transmitter glutamate. J Neurochem (1988) 0.93
Use of beta-methylene-D,L-aspartate to assess the role of aspartate aminotransferase in cerebral oxidative metabolism. J Neurochem (1983) 0.92
New insights into the compartmentation of glutamate and glutamine in cultured rat brain astrocytes. Dev Neurosci (1996) 0.91
Structural insight into the inhibition of human kynurenine aminotransferase I/glutamine transaminase K. J Med Chem (2009) 0.89
Role of aspartate aminotransferase and mitochondrial dicarboxylate transport for release of endogenously and exogenously supplied neurotransmitter in glutamatergic neurons. Neurochem Res (1989) 0.89
Effect of NMDA antagonists on the activity of glutaminase and aspartate aminotransferase in the developing rat cerebellum. Int J Dev Neurosci (1999) 0.87
Aspartate aminotransferase in synaptic and nonsynaptic mitochondria: differential effect of compounds that influence transient hetero-enzyme complex (metabolon) formation. Neurochem Int (2006) 0.86
Influence of the malate-aspartate shuttle on oxidative metabolism in synaptosomes. J Neurochem (1988) 0.84
Structural insight into the mechanism of substrate specificity of aedes kynurenine aminotransferase. Biochemistry (2008) 0.83
Mitochondrial aspartate aminotransferase: direction of a single protein with two distinct functions to two subcellular sites does not require alternative splicing of the mRNA. Biochem J (2000) 0.83
Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases. BMC Biochem (2010) 0.82
Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal muscle. Proc Nutr Soc (2004) 0.81
Actions of excitatory amino acids and kynurenic acid in the primate hippocampus: a preliminary study. Neurosci Lett (1984) 0.81
Mechanism for multiple-substrates recognition of alpha-aminoadipate aminotransferase from Thermus thermophilus. Proteins (2009) 0.80
Forced swimming and imipramine modify plasma and brain amino acid concentrations in mice. Eur J Pharmacol (2008) 0.78
Effect of potassium and N-methyl-D-aspartate on the aspartate aminotransferase activity in cultured cerebellar granule cells. J Neurosci Res (1992) 0.77
Sorting of small RNAs into Arabidopsis argonaute complexes is directed by the 5' terminal nucleotide. Cell (2008) 9.02
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology (2010) 7.86
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med (2015) 5.69
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife (2012) 5.18
Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics (2005) 4.60
Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes. Science (2007) 4.03
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol (2009) 3.28
Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell (2007) 3.06
Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell (2012) 2.87
The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. Mol Cell (2005) 2.68
KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic Acids Res (2006) 2.59
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum Mol Genet (2011) 2.34
The crystal structure of Mtr4 reveals a novel arch domain required for rRNA processing. EMBO J (2010) 2.25
Structure and ubiquitin binding of the ubiquitin-interacting motif. J Biol Chem (2003) 2.19
Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell (2013) 2.17
The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature (2008) 2.11
AlgK is a TPR-containing protein and the periplasmic component of a novel exopolysaccharide secretin. Structure (2010) 1.97
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease. Exp Neurol (2005) 1.79
Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol (2007) 1.78
Time-dependent, protein-directed growth of gold nanoparticles within a single crystal of lysozyme. Nat Nanotechnol (2011) 1.77
Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol (2005) 1.76
Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation. J Am Chem Soc (2009) 1.75
Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. FEBS Lett (2003) 1.73
Structure of the mid-region of tropomyosin: bending and binding sites for actin. Proc Natl Acad Sci U S A (2005) 1.72
Melanization immune responses in mosquito vectors. Trends Parasitol (2005) 1.71
Rationally tuning the reduction potential of a single cupredoxin beyond the natural range. Nature (2009) 1.68
The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma (2007) 1.65
Rational design of a structural and functional nitric oxide reductase. Nature (2009) 1.60
Drosophila tan encodes a novel hydrolase required in pigmentation and vision. PLoS Genet (2005) 1.59
Structural studies of a bacterial condensin complex reveal ATP-dependent disruption of intersubunit interactions. Cell (2009) 1.58
The malaria parasite Plasmodium falciparum histones: organization, expression, and acetylation. Gene (2006) 1.56
Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk (2010) 1.49
A dimerized coiled-coil domain and an adjoining part of geminin interact with two sites on Cdt1 for replication inhibition. Mol Cell (2004) 1.48
Calreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations. Leuk Lymphoma (2014) 1.45
Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278). Biochemistry (2006) 1.41
Structural basis for ubiquitin recognition by the human ESCRT-II EAP45 GLUE domain. Nat Struct Mol Biol (2006) 1.41
Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011. Orphanet J Rare Dis (2011) 1.40
Novel microRNAs uncovered by deep sequencing of small RNA transcriptomes in bread wheat (Triticum aestivum L.) and Brachypodium distachyon (L.) Beauv. Funct Integr Genomics (2009) 1.39
Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol (2011) 1.38
Identification of Drosophila melanogaster yellow-f and yellow-f2 proteins as dopachrome-conversion enzymes. Biochem J (2002) 1.37
The refined crystal structure of an eel pout type III antifreeze protein RD1 at 0.62-A resolution reveals structural microheterogeneity of protein and solvation. Biophys J (2003) 1.36
Structure of a Blm10 complex reveals common mechanisms for proteasome binding and gate opening. Mol Cell (2010) 1.36
Addition of amines to nitriles catalyzed by ytterbium amides: an efficient one-step synthesis of monosubstituted N-arylamidines. Org Lett (2008) 1.35
Roles of glutamates and metal ions in a rationally designed nitric oxide reductase based on myoglobin. Proc Natl Acad Sci U S A (2010) 1.29
Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development. J Biol Chem (2006) 1.29
Regulatory targets of quorum sensing in Vibrio cholerae: evidence for two distinct HapR-binding motifs. Nucleic Acids Res (2009) 1.28
DTF1 is a core component of RNA-directed DNA methylation and may assist in the recruitment of Pol IV. Proc Natl Acad Sci U S A (2013) 1.27
Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7. J Biol Chem (2005) 1.25
Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J Neurocytol (2004) 1.23
Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J Neurosci (2004) 1.23
Structural insight into substrate specificity of phosphodiesterase 10. Proc Natl Acad Sci U S A (2007) 1.22
Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J Biochem (2006) 1.22
miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Cancer Lett (2011) 1.21
PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains. Hum Mol Genet (2002) 1.20
Crystal structures of the BlaI repressor from Staphylococcus aureus and its complex with DNA: insights into transcriptional regulation of the bla and mec operons. J Bacteriol (2005) 1.19
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci (2009) 1.19
Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice. J Biochem (2007) 1.18
Structural models for interactions between the 20S proteasome and its PAN/19S activators. J Biol Chem (2009) 1.17
Crystal structure and RNA binding of the Tex protein from Pseudomonas aeruginosa. J Mol Biol (2008) 1.15
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. Proc Natl Acad Sci U S A (2004) 1.14
Structure of the cytoplasmic region of PelD, a degenerate diguanylate cyclase receptor that regulates exopolysaccharide production in Pseudomonas aeruginosa. J Biol Chem (2012) 1.11
Structural basis for alginate secretion across the bacterial outer membrane. Proc Natl Acad Sci U S A (2011) 1.11
Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity. Biochemistry (2008) 1.09
The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein. Genomics (2002) 1.09
H3.3-H4 tetramer splitting events feature cell-type specific enhancers. PLoS Genet (2013) 1.09
Crystal structure of the pyocyanin biosynthetic protein PhzS. Biochemistry (2008) 1.08
BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett (2008) 1.08
Crystal structure of the [Mg2+-(chromomycin A3)2]-d(TTGGCCAA)2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion. Nucleic Acids Res (2004) 1.08
Crystal structure of human kynurenine aminotransferase I. J Biol Chem (2004) 1.08
Crystal structure of Haemophilus influenzae NadR protein. A bifunctional enzyme endowed with NMN adenyltransferase and ribosylnicotinimide kinase activities. J Biol Chem (2002) 1.07
Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1. J Virol (2010) 1.06
The peptide-receptive transition state of MHC class I molecules: insight from structure and molecular dynamics. J Immunol (2012) 1.05
Characterization of two potentially universal turn motifs that shape the repeated five-residues fold--crystal structure of a lumenal pentapeptide repeat protein from Cyanothece 51142. Protein Sci (2006) 1.05
PJA1, encoding a RING-H2 finger ubiquitin ligase, is a novel human X chromosome gene abundantly expressed in brain. Genomics (2002) 1.05
pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem (2004) 1.04
Structural and functional analysis of the pyocyanin biosynthetic protein PhzM from Pseudomonas aeruginosa. Biochemistry (2007) 1.04
Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility. Hum Mutat (2012) 1.04
The splicing machinery promotes RNA-directed DNA methylation and transcriptional silencing in Arabidopsis. EMBO J (2013) 1.04
Major chorion proteins and their crosslinking during chorion hardening in Aedes aegypti mosquitoes. Insect Biochem Mol Biol (2006) 1.03
Structural insights into membrane targeting by the flagellar calcium-binding protein (FCaBP), a myristoylated and palmitoylated calcium sensor in Trypanosoma cruzi. J Biol Chem (2008) 1.02
Alternative conformations of the archaeal Nop56/58-fibrillarin complex imply flexibility in box C/D RNPs. J Mol Biol (2007) 1.02
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice. Mol Cell Biol (2004) 1.01
Profound asymmetry in the structure of the cAMP-free cAMP Receptor Protein (CRP) from Mycobacterium tuberculosis. J Biol Chem (2009) 1.01
Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures. J Am Chem Soc (2009) 1.01
Crystal structure of human kynurenine aminotransferase II. J Biol Chem (2007) 1.00
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase. Bioorg Med Chem Lett (2012) 1.00
Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase. Arch Biochem Biophys (2008) 1.00
Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochem J (2007) 1.00
A designed functional metalloenzyme that reduces O2 to H2O with over one thousand turnovers. Angew Chem Int Ed Engl (2012) 1.00
Disruption of an N-acetyltransferase gene in the silkworm reveals a novel role in pigmentation. Development (2010) 1.00
A gain-of-function mutation in the Arabidopsis disease resistance gene RPP4 confers sensitivity to low temperature. Plant Physiol (2010) 1.00
SET-domain bacterial effectors target heterochromatin protein 1 to activate host rDNA transcription. EMBO Rep (2013) 0.99
Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep (2008) 0.99